Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT04919382
Brief Title: Temozolomide and Atezolizumab as Second Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

First Submitted : June 3, 2021
First Submitted that Met QC Criteria : June 3, 2021
First Posted : June 9, 2021

Last Update Submitted that Met QC Criteria : August 18, 2021
Last Update Posted : August 19, 2021